Publicações

Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer A Clinical Trial

AuthID
P-00P-2MB

Author(s)

Royce, M

Bachelot, T

Villanueva, C

Ozguroglu, M

Azevedo, SJ

Cruz, FM

Debled, M

Hegg, R

Toyama, T

Falkson, C

Jeong, J

Srimuninnimit, V

Gradishar, WJ

Arce, C

Ridolfi, A

Lin, CJ

Cardoso, F

Document Type

Article

Year published

2018

Published

in JAMA ONCOLOGY, ISSN: 2374-2437

Volume: 4, Issue: 7, Pages: 977-984 (8)

Indexing

Wos^®

Scopus^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1001/jamaoncol.2018.0060

Scopus: 2-s2.0-85050538909

Wos: WOS:000438486000017

Source Identifiers

ISSN: 2374-2437

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer A Clinical Trial

Useful Links

Get Help

Autenticação Federada (Click on the image)

Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer A Clinical Trial

Useful Links

Get Help